CITIUS ONCOLOGY INC
CTOR·17331Y109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist
CTOR (CITIUS ONCOLOGY INC) is held by 10 institutional investors as of Q1 2026. Largest holders: BANK OF AMERICA CORP /DE/ ($2.4M), VANGUARD CAPITAL MANAGEMENT LLC ($331,591), GEODE CAPITAL MANAGEMENT, LLC ($164,107). Net institutional sentiment: Mixed.
10
Holders
Avg rating(3 Elite)
$3.1M
Total Value
58% (14)
Fund Consensus
7 buying - 5 selling
Who's Trading
ActivistCPCitius Pharmaceuticals, Inc.71.0%Jun 4, 2026
ActivistARArmistice Capital, LLC10.0%May 15, 2026
ActivistCPCitius Pharmaceuticals, Inc.77.9%Dec 17, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer